Parathyroid Cancer: The Rare Diagnosis
Written by John P. Sabra, MD FACS
Updated September 2026
Educational only. This article is not medical advice. Always consult your physician about your individual situation.
Parathyroid cancer is very rare, accounting for less than 1% of cases of primary hyperparathyroidism. When it does occur, it changes nearly every part of management. The biochemical features are more extreme, the surgical approach is fundamentally different from a typical parathyroidectomy, and lifelong surveillance is essential. Recognizing the diagnosis before surgery is the single most important step toward a good outcome.
Parathyroid cancer accounts for fewer than 1 in 200 cases of primary hyperparathyroidism. Most parathyroid overactivity is caused by a benign single adenoma or by four-gland hyperplasia. Parathyroid cancer is something else entirely: a malignant growth of parathyroid cells that produces severe hyperparathyroidism, invades surrounding tissues, and carries a meaningful risk of recurrence and distant spread over years.
The challenge is that parathyroid cancer can be hard to tell apart from a benign adenoma until the operation begins. Cytology cannot reliably diagnose it. Imaging may show a larger or more concerning lesion, but it cannot make the diagnosis with certainty. The most reliable preoperative clues are biochemical and clinical patterns that should raise suspicion.
Clues That Suggest Parathyroid Cancer
-
Severely elevated calcium (often above 13 mg/dL): Benign disease rarely produces calcium this high.
-
Markedly elevated PTH (often more than 5 to 10 times the upper limit of normal): Benign adenomas typically cause more modest PTH elevation.
-
Palpable neck mass: Benign adenomas are usually not palpable. A firm parathyroid mass on examination is suspicious.
-
Recurrent laryngeal nerve dysfunction (hoarseness) before any surgery has been performed: This suggests invasion of the nerve.
-
Severe bone disease or kidney stones at presentation: Reflects the extreme biochemical disease.
-
Significant symptoms (fatigue, weakness, severe constipation, mood changes): Often more pronounced than in benign disease.
-
Family history of parathyroid disease with cancer features: Some hereditary syndromes (HPT-JT) predispose to parathyroid cancer.
⚕ Clinical note
A patient with primary hyperparathyroidism and a calcium above 13 mg/dL, PTH more than 5 times normal, and a palpable neck mass has parathyroid cancer until proven otherwise. The surgical approach for this patient must be planned with the cancer diagnosis in mind, not as a routine focused parathyroidectomy. That single recognition can be the difference between a curative en bloc resection and an inadequate first surgery.
The Surgical Approach
The standard operation for suspected parathyroid cancer is en bloc resection of the parathyroid tumor along with the adjacent thyroid lobe and any structures that appear involved (recurrent laryngeal nerve, central neck lymph nodes, strap muscles, sometimes esophagus or trachea). This is fundamentally different from a routine parathyroidectomy, which removes only the abnormal gland and is typically very straightforward.
The reason for the broader resection is the way parathyroid cancer spreads: first by direct invasion of nearby structures, then by lymph node involvement, and only later by distant blood-borne spread. Aggressive initial resection of all involved tissue is the single most important factor for long-term cure. An inadequate first surgery goes along with high recurrence rates.
| Outcome | Approximate Rates |
|---|---|
| 5-year survival | Approximately 75 to 85% |
| 10-year survival | Approximately 50 to 70% |
| Recurrence after curative-intent surgery | Approximately 40 to 50% |
Surveillance After Treatment
Long-term surveillance for parathyroid cancer is essential and lifelong. Recurrence often shows up as gradually rising calcium and PTH over years. The pattern resembles recurrent benign hyperparathyroidism but is more aggressive. Surveillance includes:
-
Calcium and PTH: Every 3 to 6 months initially, then less frequently if stable.
-
Neck imaging: Periodic ultrasound and sometimes CT.
-
Chest imaging: The lungs are the most common site of distant spread.
-
Bone imaging: Bone is the second most common distant site.
Management of Recurrent Disease
When parathyroid cancer recurs, the management is again surgical when possible. Surgical resection of recurrent disease can produce meaningful long-term disease control even in patients who undergo multiple operations over years. For patients with unresectable or widespread disease, the most difficult clinical problem is the severe hypercalcemia rather than the cancer itself. Medications that lower calcium (cinacalcet, intravenous bisphosphonates, denosumab) become part of long-term management.
⚕ Clinical note
Genetic testing for HPT-JT syndrome (hyperparathyroidism-jaw tumor syndrome) and CDC73 gene mutations should be considered in patients diagnosed with parathyroid cancer, particularly those who are young or have a family history of parathyroid disease. A positive test has implications for family members and for surveillance.
The Bottom Line
Parathyroid cancer is rare but biologically distinct from benign parathyroid disease. The diagnostic clues are severe biochemical disease, a palpable mass, and possible nerve involvement. The surgical approach is fundamentally different: en bloc resection including the adjacent thyroid lobe rather than focused parathyroidectomy. Long-term outcomes depend heavily on the completeness of the initial surgery, and surveillance is lifelong. The diagnosis is best managed at a high-volume center experienced specifically with parathyroid cancer.
If your clinical picture suggests parathyroid cancer (severely elevated calcium and PTH, a palpable mass, or nerve dysfunction), seek surgical evaluation at a high-volume endocrine surgery center before any operation is planned.
This article is intended for patient education only. It does not constitute medical advice and does not replace a consultation with your physician. Individual patient circumstances and clinical judgment determine the appropriate evaluation and management for every patient.
More from the Parathyroid Disease series
Ready to Talk to a Specialist?
A thyroid specialist can review your specific results, answer your questions, and help you understand exactly what your next steps should be. The ATLAS network connects you with experienced thyroid and parathyroid expert physicians who focus on thyroid disease.
Find a Thyroid Specialist Near You →